Invitae (NYSE:NVTA) Receives New Coverage from Analysts at StockNews.com

StockNews.com initiated coverage on shares of Invitae (NYSE:NVTA) in a report published on Friday. The brokerage issued a hold rating on the medical research company’s stock.

Invitae Stock Performance

Invitae stock opened at $0.00 on Friday. Invitae has a 12-month low of $0.02 and a 12-month high of $0.02. The firm has a market cap of $80,103.00, a P/E ratio of 0.00 and a beta of 1.59.

About Invitae

Invitae Corporation, a medical genetics company, that provides genetic information to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, precision oncology, women's health, rare diseases, and pharmacogenomics; digital health solutions; and health data services.